Major adverse cardiovascular and bleeding outcomes in paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient-level data analysis of a large cohort of patients from the COMBINE-AF

Eur J Intern Med. 2026 Feb 18:106774. doi: 10.1016/j.ejim.2026.106774. Online ahead of print.ABSTRACTBACKGROUND: We performed an individual patient data analysis of COMBINE AF to assess differences in 14 clinically relevant outcomes between patients with paroxysmal (PAF) vs. non-PAF.METHODS: Cox-pro

G George Ntaios

A critical evaluation of the 2025-2030 Dietary Guidelines for Americans

Nutr Metab Cardiovasc Dis. 2026 Feb 6:104614. doi: 10.1016/j.numecd.2026.104614. Online ahead of print.ABSTRACTAIMS: To critically evaluate the 2025-2030 Dietary Guidelines for Americans (DGA), a key policy instrument shaping dietary advice in United States and influencing food production, healthcar

A Annalisa Giosuè

Perindopril: A comprehensive profile

Profiles Drug Subst Excip Relat Methodol. 2026;51:211-252. doi: 10.1016/bs.podrm.2025.12.001. Epub 2026 Jan 3.ABSTRACTPerindopril (PER) is classified as angiotensin-converting enzyme (ACE) inhibitors and is used primarily for the management of hypertension and cardiovascular conditions, including he

J Jude Majed Lababidi

Circulating proteomic landscape of lung function

Eur Respir J. 2026 Feb 19:2501528. doi: 10.1183/13993003.01528-2025. Online ahead of print.ABSTRACTBACKGROUND: Large-scale genetic and epigenetic studies have identified numerous genes linked to lung function. However, proteomics, which can offer more direct insights into pathophysiologic processes,

M Mikyeong Lee